Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone in ACL Reconstruction (TACL)
NCT01595581Phase 3Completed
- Sponsor
- University of Southern California
- Start
- Apr 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in muscle atrophy comparing Testosterone with Placebo (2 arms). Primary endpoint: Changes in Lean Mass at 24 weeks. Started Apr 2012; status: completed.
02
Drugs
testosterone
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT01595581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595581.